Literature DB >> 19919527

Regulation of multiple cytokine signalling pathways by SOCS3 is independent of SOCS2.

Hiu Kiu1, Christopher J Greenhalgh, Anne Thaus, Douglas J Hilton, Nicos A Nicola, Warren S Alexander, Andrew W Roberts.   

Abstract

Suppressor of cytokine signalling (SOCS) 3 is an essential regulator of cytokine signalling, and in turn its expression is tightly regulated. Data from overexpression studies in cell lines suggest that SOCS2 regulates SOCS3 protein degradation, by forming a molecular bridge to an E3 ubiquitin-ligase complex. Whether this regulation is relevant in primary cells is unknown. In this study, we utilized Socs2( - / - ) mice to examine the role of SOCS2 in modulating SOCS3 expression and degradation, and its impact on interleukin-2 (IL-2) and IL-6 signalling in primary haemopoietic cells. Both biochemical and biological analyses demonstrated unperturbed SOCS3 expression and cytokine signalling in the absence of SOCS2. Our results suggest that SOCS2 is not a physiological regulator of SOCS3 expression and action in primary haemopoietic cells.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19919527      PMCID: PMC3412171          DOI: 10.3109/08977190903210954

Source DB:  PubMed          Journal:  Growth Factors        ISSN: 0897-7194            Impact factor:   2.511


  48 in total

Review 1.  The many faces of the SOCS box.

Authors:  Julie Piessevaux; Delphine Lavens; Frank Peelman; Jan Tavernier
Journal:  Cytokine Growth Factor Rev       Date:  2008-10-22       Impact factor: 7.638

2.  Suppressor of cytokine signaling-3 preferentially binds to the SHP-2-binding site on the shared cytokine receptor subunit gp130.

Authors:  S E Nicholson; D De Souza; L J Fabri; J Corbin; T A Willson; J G Zhang; A Silva; M Asimakis; A Farley; A D Nash; D Metcalf; D J Hilton; N A Nicola; M Baca
Journal:  Proc Natl Acad Sci U S A       Date:  2000-06-06       Impact factor: 11.205

3.  Suppressor of cytokine signaling 3 (SOCS-3) protects beta -cells against interleukin-1beta - and interferon-gamma -mediated toxicity.

Authors:  A E Karlsen; S G Rønn; K Lindberg; J Johannesen; E D Galsgaard; F Pociot; J H Nielsen; T Mandrup-Poulsen; J Nerup; N Billestrup
Journal:  Proc Natl Acad Sci U S A       Date:  2001-10-02       Impact factor: 11.205

4.  Regulation of Socs gene expression by the proto-oncoprotein GFI-1B: two routes for STAT5 target gene induction by erythropoietin.

Authors:  Armin G Jegalian; Hong Wu
Journal:  J Biol Chem       Date:  2001-11-05       Impact factor: 5.157

5.  The Stat1 binding motif of the interferon-gamma receptor is sufficient to mediate Stat5 activation and its repression by SOCS3.

Authors:  I Woldman; L Varinou; K Ramsauer; B Rapp; T Decker
Journal:  J Biol Chem       Date:  2001-09-27       Impact factor: 5.157

6.  Placental defects and embryonic lethality in mice lacking suppressor of cytokine signaling 3.

Authors:  A W Roberts; L Robb; S Rakar; L Hartley; L Cluse; N A Nicola; D Metcalf; D J Hilton; W S Alexander
Journal:  Proc Natl Acad Sci U S A       Date:  2001-07-31       Impact factor: 11.205

7.  Gigantism in mice lacking suppressor of cytokine signalling-2.

Authors:  D Metcalf; C J Greenhalgh; E Viney; T A Willson; R Starr; N A Nicola; D J Hilton; W S Alexander
Journal:  Nature       Date:  2000-06-29       Impact factor: 49.962

8.  Interleukin 9 induces expression of three cytokine signal inhibitors: cytokine-inducible SH2-containing protein, suppressor of cytokine signalling (SOCS)-2 and SOCS-3, but only SOCS-3 overexpression suppresses interleukin 9 signalling.

Authors:  D Lejeune; J B Demoulin; J C Renauld
Journal:  Biochem J       Date:  2001-01-01       Impact factor: 3.857

9.  A new high affinity binding site for suppressor of cytokine signaling-3 on the erythropoietin receptor.

Authors:  Michael Hörtner; Ulrich Nielsch; Lorenz M Mayr; Peter C Heinrich; Serge Haan
Journal:  Eur J Biochem       Date:  2002-05

Review 10.  SOCS regulation of the JAK/STAT signalling pathway.

Authors:  Ben A Croker; Hiu Kiu; Sandra E Nicholson
Journal:  Semin Cell Dev Biol       Date:  2008-07-30       Impact factor: 7.727

View more
  11 in total

1.  SOCS3 deletion in B cells alters cytokine responses and germinal center output.

Authors:  Sarah A Jones; Christine A White; Lorraine Robb; Warren S Alexander; David M Tarlinton
Journal:  J Immunol       Date:  2011-11-09       Impact factor: 5.422

Review 2.  Erythropoietin receptor response circuits.

Authors:  Don M Wojchowski; Pradeep Sathyanarayana; Arvind Dev
Journal:  Curr Opin Hematol       Date:  2010-05       Impact factor: 3.284

3.  Reduced Socs3 expression in adipose tissue protects female mice against obesity-induced insulin resistance.

Authors:  R Palanivel; M D Fullerton; S Galic; J Honeyman; K A Hewitt; S B Jorgensen; G R Steinberg
Journal:  Diabetologia       Date:  2012-08-08       Impact factor: 10.122

4.  Extended anti-inflammatory action of a degradation-resistant mutant of cell-penetrating suppressor of cytokine signaling 3.

Authors:  Tynetta C Fletcher; Antonio DiGiandomenico; Jacek Hawiger
Journal:  J Biol Chem       Date:  2010-04-16       Impact factor: 5.157

5.  Mechanisms of reduced leptin-mediated satiety signaling during obesity.

Authors:  Sung Jin Park; Yang Yu; Carter G Zides; Michael J Beyak
Journal:  Int J Obes (Lond)       Date:  2022-03-03       Impact factor: 5.551

Review 6.  Suppressors of cytokine signaling (SOCS) in T cell differentiation, maturation, and function.

Authors:  Douglas C Palmer; Nicholas P Restifo
Journal:  Trends Immunol       Date:  2009-10-30       Impact factor: 16.687

7.  SOCS2 is dispensable for BCR/ABL1-induced chronic myeloid leukemia-like disease and for normal hematopoietic stem cell function.

Authors:  N Hansen; H Ågerstam; M Wahlestedt; N Landberg; M Askmyr; M Ehinger; M Rissler; H Lilljebjörn; P Johnels; J Ishiko; J V Melo; W S Alexander; D Bryder; M Järås; T Fioretos
Journal:  Leukemia       Date:  2012-06-22       Impact factor: 11.528

Review 8.  SOCS3: An essential physiological inhibitor of signaling by interleukin-6 and G-CSF family cytokines.

Authors:  Christine A White; Nicos A Nicola
Journal:  JAKSTAT       Date:  2013-06-11

9.  Role of Ubiquitylation in Controlling Suppressor of Cytokine Signalling 3 (SOCS3) Function and Expression.

Authors:  Jamie J L Williams; Kirsten M A Munro; Timothy M Palmer
Journal:  Cells       Date:  2014-05-30       Impact factor: 6.600

10.  Deletion of skeletal muscle SOCS3 prevents insulin resistance in obesity.

Authors:  Sebastian Beck Jorgensen; Hayley M O'Neill; Lykke Sylow; Jane Honeyman; Kimberly A Hewitt; Rengasamy Palanivel; Morgan D Fullerton; Lisa Öberg; Anudharan Balendran; Sandra Galic; Chris van der Poel; Ian A Trounce; Gordon S Lynch; Jonathan D Schertzer; Gregory R Steinberg
Journal:  Diabetes       Date:  2012-09-06       Impact factor: 9.461

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.